Scout | Adjuvant Discovery and Down-Selection for Vaccines against Infectious and Immune-Mediated Diseases

This opportunity is no longer accepting applications.

grant

Adjuvant Discovery and Down-Selection for Vaccines against Infectious and Immune-Mediated Diseases

This grant opportunity aims to support research in discovering and developing new vaccine adjuvant candidates or categorizing existing ones for use in creating novel vaccines. Funding is available through SBIR for either Fast-Track or Direct-to-Phase II proposals, with 1 to 3 anticipated awards. The budget allows up to $300,000 annually for Phase I (up to 2 years) and $1,000,000 annually for P…

Source

Agency: National Institutes of Health

Program: SBIR

Dates

Opportunity Released: August 2, 2024

Open for Submission: August 2, 2024

Application Window Closes: October 18, 2024

Keywords

1. Vaccine Adjuvants 2. Immune-Mediated Diseases 3. Autoimmune Diseases 4. Allergic Diseases 5. Tolerogenic Adjuvants 6. Immunotherapy 7. Infectious Diseases 8. Transplant Rejection 9. Innate Immune Mechanisms 10. Novel Vaccine Development

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers